Comparison

Lapatinib ditosylate monohydrate European Partner

Item no. TMO-T0078L-25mg
Manufacturer TargetMol
CASRN 388082-78-8
Amount 25 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 200 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,98
Smiles n1cnc(c2cc(ccc12)c1oc(cc1)CNCCS(=O)(=O)C)Nc1cc(c(cc1)OCc1cc(ccc1)F)Cl.c1(ccc(cc1)C)S(=O)(=O)O.O.c1(ccc(cc1)C)S(=O)(=O)O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Lapatinib ditoluenesulfonate monohydrate,Tyverb ditosylate monohydrate,Lapatinib ditosylate monohydrate,Tykerb ditosylate monohydrate,Lapatinib ditosilate hydrate
Similar products 388082-78-8
Shipping Condition Cool pack
Available
Manufacturer - Targets
Ferroptosis|||EGFR|||Autophagy
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
943.47
Description
Lapatinib ditosylate (Lapatinib tosilate) monohydrate is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib ditosylate monohydrate therapy is associated with transient elevations in serum aminotransferase levels and rare instances of clinically apparent acute liver injury.
Pathways
JAK/STAT signaling|||Apoptosis|||Autophagy|||Angiogenesis|||Tyrosine Kinase/Adaptors
Formulate
C29H26ClFN4O4S· 2(C7H8O3S)· H2O

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close